tiprankstipranks
Trending News
More News >
Denali Therapeutics (DNLI)
NASDAQ:DNLI
US Market

Denali Therapeutics (DNLI) Cash flow

Compare
820 Followers

Denali Therapeutics Cash Flow

DNLI's free cash flow for Q3 2025 was $-105.92M. For the 2025 fiscal year, DNLI's free cash flow was decreased by $7.32M and operating cash flow was $-107.30M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -347.69M$ -357.99M$ -244.72M$ -211.39M$ 416.15M
Investing Cash Flow
$ -88.76M$ 249.31M$ -141.39M$ -21.63M$ -623.21M
Financing Cash Flow
$ 484.30M$ 17.82M$ 310.67M$ 19.35M$ 634.75M
End Cash Position
$ 176.53M$ 127.11M$ 219.54M$ 294.98M$ 508.64M
Free Cash Flow
$ -363.61M$ -370.93M$ -262.55M$ -219.89M$ 413.06M
Currency in USD

Denali Therapeutics Cash Flow